Meetings

Leaders and research scientists from UL Research Institutes’ Electrochemical Safety Research Institute will present insights and findings at the 250th Meeting of The Electrochemical Society from Oct. 25-29 in Calgary, Canada. The team’s scientific research focuses on challenges facing battery manufacturers, integrators, and end users, including limiting lithium-ion thermal-runaway propagation, characterizing sodium-ion safety and emissions, and strengthening recycling and failure-analysis methods.

The European Society for Medical Oncology (ESMO) is holding its annual congress from 23 to 27 October in Madrid, Spain. This major international event provides oncologists and researchers from around the world with an opportunity to present the latest findings from clinical studies aimed at improving cancer care and deepening our understanding of the disease. Once again, this year, physicians and researchers from Gustave Roussy have contributed to several dozen studies that will be presented during the five-day congress.

Insilico Medicine will present first-in-human Phase 1 data on ISM6331, an investigational oral pan-TEAD inhibitor designed using its generative AI platform, Chemistry42, at the ESMO Congress 2026 in Madrid. The ongoing multicenter study evaluates safety, tolerability, pharmacokinetics and preliminary antitumor activity in patients with mesothelioma or other advanced solid tumors. Melina E. Marmarelis, MD, of the University of Pennsylvania, will present updated findings on October 25.

The International Society for Stem Cell Research (ISSCR) today opens its international symposium celebrating the 20th anniversary of induced pluripotent stem (iPS) cell technology, bringing together scientists, clinicians, and innovators from around the world to reflect on two decades of transformative discoveries and explore the future of stem cell research and regenerative medicine.

The three-day symposium, held Oct. 20–22 in Kyoto, Japan, is organized in partnership with the Center for iPS Cell Research and Application (CiRA) and co-sponsored by the Japanese Society for Regenerative Medicine (JSRM).

The extraordinary response to the symposium underscores the strength and momentum of stem cell science worldwide. Registration reached capacity twice, even after the ISSCR expanded the meeting to a larger venue to accommodate growing demand. This remarkable level of interest reflects both the profound impact of iPSC technology over the past two decades and the expanding opportunities ahead, from fundamental discoveries in human biology to advances in disease modeling, drug discovery, clinical translation, and the development of stem cell-based therapies.

The 2026 International Engineering Symposium on Energy Frontiers is jointly organized by Shanghai Jiao Tong University, The Hong Kong Polytechnic University, and the ENGINEERING Energy journal. Scheduled to take place in Hong Kong from December 10 to 12, 2026, the symposium is dedicated to frontier exploration, scientific and technological innovation, and interdisciplinary integration in the energy sector. It aims to showcase cutting-edge academic achievements and innovative applications from across the global energy community.